Implementation of pharmacogenetic testing in oncology: DPYD-guided dosing to prevent fluoropyrimidine toxicity in British Columbia

Background: Fluoropyrimidine toxicity is often due to variations in the gene (DPYD) encoding dihydropyrimidine dehydrogenase (DPD). DPYD genotyping can be used to adjust doses to reduce the likelihood of fluoropyrimidine toxicity while maintaining therapeutically effective drug levels.Methods: A mul...

Ausführliche Beschreibung

Bibliografische Detailangaben

Hauptverfasser:	Angela Wu, Helen Anderson, Curtis Hughesman, Sean Young, Caroline Lohrisch, Colin J. D. Ross, Bruce C. Carleton
Format:	Artigo
Sprache:	Inglês
Veröffentlicht:	Frontiers Media S.A. 2023-09-01
Schriftenreihe:	Frontiers in Pharmacology
Schlagworte:	adverse drug reactions clinical implementation DPYD fluoropyrimidine toxicity pharmacogenetics
Online-Zugang:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1257745/full
Tags:	Tag hinzufügen Keine Tags, Fügen Sie das erste Tag hinzu!